Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
China Resources Dubl Crne Phrmctl (600062 CH)
Watchlist
24
Analysis
Health Care
•
China
China Resources Double-Crane Pharmaceutical Co., Ltd. develops, manufactures and markets a variety of medical products. The Company's products include anti-influenza, antihypertensives, and antibiotics.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Resources Beverage
•
07 Aug 2024 09:48
China Resources Beverage Pre-IPO - Peer Comparison - Middling
China Resources Beverage is looking to raise US$1bn in its upcoming Hong Kong IPO. We have looked at the company's past performance in our previous...
Sumeet Singh
Follow
304 Views
Share
bullish
•
Oneness Biotech
•
23 Jul 2024 09:30
Oneness Biotech (4743 TT): Marketing Progress of Fespixon in China Opens a New Revenue Stream
Oneness Biotech partners with CR Double Crane for exclusive commercialization of Fespixon in China, Hong Kong, and Macau. Fespixon is approved in...
Tina Banerjee
Follow
318 Views
Share
bullish
•
Tencent
•
04 May 2024 00:35
Upgrading Emerging Markets to Market Weight; China/Hong Kong Continue to Bottom; Energy Breakdowns
Upgrading Emerging Markets $EEM $VWO to Market Weight; China/Hong Kong Continue to Bottom $FXI $MCHI $KWEB; Lows Likely in on $ACWI; Commodities...
Vermilion Research
Follow
448 Views
Share
bullish
•
China Resources Beverage
•
30 Apr 2024 09:54
China Resources Beverage Pre-IPO - The Positives - Strong Position in Its Main Market
China Resources Beverage is looking to raise US$1bn in its upcoming Hong Kong IPO. In this ntoe, we talk about the positive aspects of the deal.
Sumeet Singh
Follow
420 Views
Share
bullish
•
China Resources Beverage
•
25 Apr 2024 10:10
China Resources Beverage (Holdings) Pre-IPO Tearsheet
China Resources Beverage (Holdings) Company Limited is looking to raise US$1bn in its upcoming Hong Kong IPO. The bookrunners on the deal are BofA,...
Sumeet Singh
Follow
483 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x